Hypertension
The production of angiotensinogen is increased by corticosteroids, estrogens, thyroid hormones, and ANG II.
ACE inhibitors block the bradykinin metabolism and thus the increase in bradykinin levels leads to a common side effect of ACE inhibitors which is a dry cough whereas Angiotensin receptor blockers do not influence bradykinin metabolism and thus no dry cough is experienced.
ACE inhibitors block the conversion ANG I and ANG II as well the metabolism of bradykinin to an inactive metabolite. ANG II causes an increase in Blood pressure thus by blocking the conversion of ANG I to ANG II ACE inhibitors decrease blood pressure
Losartan and other similar drugs are specific competitive antagonists at angiotensin AT1 receptors
They do influence AT2 receptors when ANG II is increased
Kinins are potent vasodilators and increase the blood flow in the body.
Autocoids such as Histamine and Serotonin also play a role in this action.
Histamine - H1 and H2 receptors dilatate blood vessels and capillaries
Serotonin- 5-HT2receptors for vasoconstricting activity in most blood vessels and 5-HT1 for vasodilating activity
Beta 2 receptor
Natriuretic peptides increase sodium and water excretion and causes vasodilation. The excretion of sodium and water decreases volume of fluid leading to a decrease in blood pressure while the vasodilation causes blood to flow easier and thus reduces blood pressure.
Neprylisine is a neutral endopeptidase responsible for degradation of natriuretic peptides in kidneys, liver, and lungs. Neprylisine inhibitors prevent the degradation of natriuretic peptides, increases ANP and BNP and causes natriuresis and and diuresis.
A drug used as such is Sacubitril.
Vasodilators: Nitric oxide and PGI2
Vasoconstrictors: ET1